Figure 1‑1: Laparoscopic Device Market Share Ranking by Segment, U.S., 2022 (1 of 2) | 6 |
Figure 1‑2: Laparoscopic Device Market Share Ranking by Segment, U.S., 2022 (2 of 2) | 6 |
Figure 1‑3: Companies Researched in This Report | 7 |
Figure 1‑4: Factors Impacting the Laparoscopic Device Market by Segment, U.S. (1 of 2) | 8 |
Figure 1‑5: Factors Impacting the Laparoscopic Device Market by Segment, U.S. (2 of 2) | 9 |
Figure 1‑6: Recent Events in the Laparoscopic Device Market, U.S., 2020 – 2022 | 10 |
Figure 1‑7: Laparoscopic Device Procedures Covered (1 of 2) | 11 |
Figure 1‑8: Laparoscopic Device Procedures Covered (2 of 2) | 12 |
Figure 1‑9: Procedure Codes Investigated | 13 |
Figure 1‑10: Laparoscopic Device Markets Covered (1 of 3) | 14 |
Figure 1‑11: Laparoscopic Device Markets Covered (2 of 3) | 15 |
Figure 1‑12: Laparoscopic Device Markets Covered (3 of 3) | 16 |
Figure 1‑13: Key Report Updates | 17 |
Figure 1‑14: Version History | 18 |
Figure 2‑1: Laparoscopic Device Market by Segment, Worst Case Scenario, U.S., 2019 – 2029 (US$M) (1 of 2) | 35 |
Figure 2‑2: Laparoscopic Device Market by Segment, Worst Case Scenario, U.S., 2019 – 2029 (US$M) (2 of 2) | 36 |
Figure 2‑3: Laparoscopic Device Market by Segment, Base Case Scenario, U.S., 2019 – 2029 (US$M) (1 of 2) | 37 |
Figure 2‑4: Laparoscopic Device Market by Segment, Base Case Scenario, U.S., 2019 – 2029 (US$M) (2 of 2) | 38 |
Figure 2‑5: Laparoscopic Device Market by Segment, Best Case Scenario, U.S., 2019 – 2029 (US$M) (1 of 2) | 39 |
Figure 2‑6: Laparoscopic Device Market by Segment, Best Case Scenario, U.S., 2019 – 2029 (US$M) (2 of 2) | 40 |
Figure 4‑1: Laparoscopes by Company | 62 |
Figure 4‑2: Access Devices by Company | 64 |
Figure 4‑3: Laparoscopic Hand Instruments by Company (1 of 2) | 65 |
Figure 4‑4: Laparoscopic Hand Instruments by Company (2 of 2) | 66 |
Figure 4‑5: Insufflation Devices by Company (1 of 2) | 67 |
Figure 4‑6: Insufflation Devices by Company (2 of 2) | 68 |
Figure 4‑7: Suction-Irrigation Devices by Company | 69 |
Figure 4‑8: Direct Energy Devices by Company (1 of 2) | 71 |
Figure 4‑9: Direct Energy Devices by Company (2 of 2) | 72 |
Figure 4‑10: Ultrasonic Devices by Company | 73 |
Figure 4‑11: Hand-Assisted Laparoscopic Sleeves by Company | 74 |
Figure 4‑12: Closure Devices by Company | 76 |
Figure 4‑13: Gastric Devices by Company | 77 |
Figure 4‑14: Powered Morcellators by Company | 78 |
Figure 4‑15: Class 2 Device Recall Stryker Video Processor/Illuminator | 79 |
Figure 4‑16: Class 2 Device Recall GelPOINT Path Transanal Procedural Pack | 80 |
Figure 4‑17: Class 2 Device Recall Kii Fios Advanced Access System | 80 |
Figure 4‑18: Class 2 Device Recall GelPOINT Path Transanal Procedural Pack | 80 |
Figure 4‑19: Class 2 Device Recall Endopath Xcel with Optiview Technology | 81 |
Figure 4‑20: Class 2 Device Recall YelloPort Elite | 81 |
Figure 4‑21: Class 2 Device Recall Step Bladeless Trocars | 81 |
Figure 4‑22: Class 2 Device Recall VersaOne Reusable Positioning Cannula | 82 |
Figure 4‑23: Class 2 Device Recall Epix latis Grasper | 83 |
Figure 4‑24: Class 2 Device Recall Prestige | 83 |
Figure 4‑25: Class 2 Device Recall CareFusion V. Mueller | 83 |
Figure 4‑26: Class 2 Device Recall ConMed Anchor Tissue Retrieval System | 84 |
Figure 4‑27: Class 2 Device Recall Covidien Endo Grasp | 84 |
Figure 4‑28: Class 2 Device Recall Covidien Endo Clinch II | 84 |
Figure 4‑29: Class 2 Device Recall ConMed 50L Abdominal Insufflator | 85 |
Figure 4‑30: Class 3 Device Recall Insufflation Tubing Set, with Gas Filter | 85 |
Figure 4‑31: Class 2 Device Recall Stryker High Flow II Tube Set for PNEUMO SURE High Flow Insufflator | 85 |
Figure 4‑32: Class 2 Device Recall Stryker High Flow Tube Set with RealTime Pressure Sensing (RTP) for Pneumo Sure High Flow Insufflator | 85 |
Figure 4‑33: Class 2 Device Recall PNEUMOCLEAR | 86 |
Figure 4‑34: Class 2 Device Recall HydroSurg Plus Laparoscopic Irrigator | 87 |
Figure 4‑35: Class 2 Device Recall XStream Irrigation System | 87 |
Figure 4‑36: Class 2 Device Recall SafeAir Telescopic Smoke | 87 |
Figure 4‑37: Class 2 Device Recall Telescopic Smoke Evac Pencil, PB, Coated | 87 |
Figure 4‑38: Class 2 Device Recall StrykeFlow 2 Suction/Irrigator | 88 |
Figure 4‑39: Class 2 Device Recall CAIMAN DISP.INSTR.ARTICULAT.D | 89 |
Figure 4‑40: Class 2 Device Recall LigaSure Blunt Tip Laparoscopic Sealer/Divider, NanoCoated | 89 |
Figure 4‑41: Class 2 Device Recall Covidien Force TriVerse Electrosurgical Devices | 89 |
Figure 4‑42: Class 2 Device Recall Covidien Force TriVerse electrosurgical device | 89 |
Figure 4‑43: Class 2 Device Recall Ethicon | 90 |
Figure 4‑44: Class 2 Device Recall Ethicon | 91 |
Figure 4‑45: Class 2 Device Recall Covidien | 91 |
Figure 4‑46: Class 2 Device Recall HARMONIC ACE7, Shears with Advanced Hemostasis | 91 |
Figure 4‑47: Class 2 Device Recall Clip Applier Kit | 92 |
Figure 4‑48: Class 2 Device Recall Ethicon | 92 |
Figure 4‑49: Class 2 Device Recall LIGAMAX | 92 |
Figure 4‑50: Device Recall Straight Intraluminal Staplers, 33mm Diameter, Model SDH33A | 93 |
Figure 4‑51: Class 1 Device Recall Endoscopic Curved Intraluminal Stapler, 21 mm Diameter, Model ECS21A | 93 |
Figure 4‑52: Class 2 Device Recall Da Vinci S/Si | 93 |
Figure 4‑53: Class 2 Device Recall Da Vinci X/Xi | 94 |
Figure 4‑54: Class 2 Device Recall TriStaple 2.0 Black Intelligent Reload | 94 |
Figure 4‑55: Class 2 Device Recall Covidien | 94 |
Figure 4‑56: Class 2 Device Recall Covidien Endo GIA Ultra Universal stapler | 95 |
Figure 4‑57: Class 2 Device Recall PneumoLiner | 96 |
Figure 4‑58: Subserosal Laparoscopic Cholecystectomy | 98 |
Figure 4‑59: Laparoscope Anatomical and Aon-anatomical Hepatectomy | 98 |
Figure 4‑60: 3-Dimensional Versus 2-Dimensional Laparoscopy for Hysterectomy | 98 |
Figure 4‑61: Does Using a 5 mm Telescope in Laparoscopic Cholecystectomy Reduce the Incidence of Trocar Site Hernia? | 99 |
Figure 4‑62: Trocar Site Hernia After Laparoscopic Cholecystectomy, Supra Versus Infraumbilical Incision for Umbilical Trocar Entry (HOT) | 99 |
Figure 4‑63: Which Trocar Access Site Should We Use in Laparoscopic Appendectomy? | 99 |
Figure 4‑64: Laparoscopic Surgery: Comparison of Conventional Trocars to the Teleflex® MiniLap® System (MiniTroc) | 100 |
Figure 4‑65: Lexion AP 50/30 Warmed Humidified Real Time CO2 Insufflation vs Airseal Recirculated CO2/Air Insufflation in Minimally Invasive Bariatric (Gastric Bypass) Surgery | 101 |
Figure 4‑66: Post Operative Pain After Laparoscopic Hysterectomy Using Airseal® Versus Standard Insufflation System (AIRSEAL) | 101 |
Figure 4‑67: CO2 vs Air Insufflation in Children Undergoing PEG | 102 |
Figure 4‑68: Comparison of Carbon Dioxide (CO2) to Air Insufflation in Colonoscopy in Patients with Inflammatory Bowel Disease (CO2-IBD) | 102 |
Figure 4‑69: Gastric Insufflation During Positive Pressure Ventilation | 102 |
Figure 4‑70: Post Operative Pain After Laparoscopic Hysterectomy Using Airseal® Versus Standard Insufflation System (AIRSEAL) | 103 |
Figure 4‑71: Feasibility of the Ultravision™ System in Low Pressure Laparoscopic Cholecystectomy Compared to Airseal® IFS | 103 |
Figure 4‑72: Use of Antibiotic Irrigation to Decrease Wound Infections in Pediatric Perforated Appendicitis (PA Protocol) | 104 |
Figure 4‑73: Cholecystectomy Blunt Dissection | 104 |
Figure 4‑74: Irrigation and Suction Trial to Prevent SSI (I&S) | 104 |
Figure 4‑75: A Prospective, Single-Arm Multi-Center Study of the ENSEAL X1 Curved Jaw Tissue Sealer in Select Procedures | 105 |
Figure 4‑76: A Study of the ENSEAL® X1 Curved Jaw Tissue Sealer and Generator G11 in Thoracic, Urologic and Ear, Nose and Throat (ENT) Procedures | 105 |
Figure 4‑77: Comparative Study Between Ligasure Versus Conventional Vessel Ligation in Thyroidectomy | 106 |
Figure 4‑78: A Prospective, Multi-Center Evaluation of the ENSEAL X1 Large Jaw Tissue Sealer | 106 |
Figure 4‑79: A Study of ECHELON 3000 (Next Generation Powered Stapler) in General Abdominal and Thoracic Lung Resection Procedures | 107 |
Figure 4‑80: Assessing the Safety and Performance of the easyEndoTM Universal Linear Cutting Stapler in Laparoscopic Gastric Bypass Surgery | 107 |
Figure 4‑81: Study of ECHELON ENDOPATH(TM) Staple Line Reinforcement | 108 |
Figure 4‑82: Utility of OverStitch Sx After ESD | 108 |
Figure 4‑83: Sleeve Gastrectomy Outcomes with Different Stapling Devices | 108 |
Figure 4‑84: Endostapler Hemostasis Study Protocol | 109 |
Figure 4‑85: Analysis of Endoloops, Endostaples and Endoclips for Closing the Appendiceal Stump During Laparoscopic Appendectomy | 109 |
Figure 4‑86: The GATE Trial: Endoscopic Sutured Gastroplasty in Type 2 Diabetic, Obese Patients Using the Endomina Device (GATE) | 110 |
Figure 4‑87: Comparison Between Gastric Band, Laparoscopic Sleeve Gastrectomy, Gastric Bypass Surgeries | 110 |
Figure 4‑88: Intragastric Balloon in Obese Adolescents with Comorbidities (IGB) | 110 |
Figure 4‑89: The BALLOON- (BALLOon Treatment for Obesity in Norway) Pilot Study | 111 |
Figure 4‑90: ORBERA™ Post-Approval Study (OPAS-1) | 111 |
Figure 4‑91: Safety and Efficacy of Using PK Morcellator with Pneumoliner Containment Hysterectomy | 112 |
Figure 4‑92: Containment System for Laparoscopic Tissue Morcellation | 112 |
Figure 4‑93: Efficacy of In-bag Morcellation (FIBROSAC) | 112 |
Figure 5‑1: Laparoscopic Device Market by Segment, U.S., 2019 – 2029 (US$M) (1 of 2) | 116 |
Figure 5‑2: Laparoscopic Device Market by Segment, U.S., 2019 – 2029 (US$M) (2 of 2) | 117 |
Figure 5‑3: Leading Competitors, Laparoscopic Device Market, U.S., 2022 (1 of 2) | 130 |
Figure 5‑4: Leading Competitors, Laparoscopic Device Market, U.S., 2022 (2 of 2) | 131 |
Figure 5‑5: SWOT Analysis, Applied Medical | 149 |
Figure 5‑6: SWOT Analysis, B. Braun | 150 |
Figure 5‑7: SWOT Analysis, Becton Dickinson | 151 |
Figure 5‑8: SWOT Analysis, CONMED | 152 |
Figure 5‑9: SWOT Analysis, Ethicon (J&J) | 153 |
Figure 5‑10: SWOT Analysis, Karl Storz | 154 |
Figure 5‑11: SWOT Analysis, Medtronic | 155 |
Figure 5‑12: SWOT Analysis, Olympus | 156 |
Figure 5‑13: SWOT Analysis, Richard Wolf | 157 |
Figure 5‑14: SWOT Analysis, Stryker | 158 |
Figure 6‑1: Procedure Codes Investigated, U.S., 2022 | 159 |
Figure 6‑2: Open and Laparoscopic Procedures, U.S., 2019 – 2029 | 161 |
Figure 6‑3: Open Procedures by Indication, U.S., 2019 – 2029 (1 of 2) | 164 |
Figure 6‑4: Open Procedures by Indication, U.S., 2019 – 2029 (2 of 2) | 165 |
Figure 6‑5: Laparoscopic Procedures by Indication, U.S., 2019 – 2029 (1 of 2) | 166 |
Figure 6‑6: Laparoscopic Procedures by Indication, U.S., 2019 – 2029 (2 of 2) | 167 |
Figure 6‑7: Gastric Band Procedures by Placement/Removal, U.S., 2019 – 2029 | 169 |
Figure 6‑8: Inpatient Gastric Band Procedures by Placement/Removal, U.S., 2019 – 2029 | 170 |
Figure 6‑9: Outpatient Gastric Band Procedures by Placement/Removal, U.S., 2019 – 2029 | 171 |
Figure 6‑10: Gastric Balloon Procedures, U.S., 2019 – 2029 | 172 |
Figure 6‑11: Gastric Bypass Procedures by Approach, U.S., 2019 – 2029 | 174 |
Figure 6‑12: Inpatient Gastric Bypass Procedures by Approach, U.S., 2019 – 2029 | 175 |
Figure 6‑13: Outpatient Gastric Bypass Procedures by Approach, U.S., 2019 – 2029 | 176 |
Figure 6‑14: Sleeve Gastrectomy Procedures by Approach, U.S., 2019 – 2029 | 178 |
Figure 6‑15: Inpatient Sleeve Gastrectomy Procedures by Approach, U.S., 2019 – 2029 | 179 |
Figure 6‑16: Outpatient Sleeve Gastrectomy Procedures by Approach, U.S., 2019 – 2029 | 180 |
Figure 6‑17: Anti-Reflux Procedures by Approach, U.S., 2019 – 2029 | 182 |
Figure 6‑18: Inpatient Anti-Reflux Procedures by Approach, U.S., 2019 – 2029 | 183 |
Figure 6‑19: Outpatient Anti-Reflux Procedures by Approach, U.S., 2019 – 2029 | 184 |
Figure 6‑20: Colectomy Procedures by Approach, U.S., 2019 – 2029 | 186 |
Figure 6‑21: Inpatient Colectomy Procedures by Approach, U.S., 2019 – 2029 | 187 |
Figure 6‑22: Outpatient Colectomy Procedures by Approach, U.S., 2019 – 2029 | 188 |
Figure 6‑23: Cholecystectomy Procedures by Approach, U.S., 2019 – 2029 | 190 |
Figure 6‑24: Inpatient Cholecystectomy Procedures by Approach, U.S., 2019 – 2029 | 191 |
Figure 6‑25: Outpatient Cholecystectomy Procedures by Approach, U.S., 2019 – 2029 | 192 |
Figure 6‑26: Nephrectomy Procedures by Approach, U.S., 2019 – 2029 | 194 |
Figure 6‑27: Inpatient Nephrectomy Procedures by Approach, U.S., 2019 – 2029 | 195 |
Figure 6‑28: Outpatient Nephrectomy Procedures by Approach, U.S., 2019 – 2029 | 196 |
Figure 6‑29: Appendectomy Procedures by Approach, U.S., 2019 – 2029 | 198 |
Figure 6‑30: Inpatient Appendectomy Procedures by Approach, U.S., 2019 – 2029 | 199 |
Figure 6‑31: Outpatient Appendectomy Procedures Approach, U.S., 2019 – 2029 | 200 |
Figure 6‑32: Adrenalectomy Procedures by Approach, U.S., 2019 – 2029 | 202 |
Figure 6‑33: Inpatient Adrenalectomy Procedures by Approach, U.S., 2019 – 2029 | 203 |
Figure 6‑34: Outpatient Adrenalectomy Procedures by Approach, U.S., 2019 – 2029 | 204 |
Figure 6‑35: Hernia Repair Procedures by Approach, U.S., 2019 – 2029 | 206 |
Figure 6‑36: Inpatient Hernia Repair Procedures by Approach, U.S., 2019 – 2029 | 207 |
Figure 6‑37: Outpatient Hernia Repair Procedures by Approach, U.S., 2019 – 2029 | 208 |
Figure 6‑38: Hysterectomy Procedures by Approach, U.S., 2019 – 2029 | 210 |
Figure 6‑39: Inpatient Hysterectomy Procedures by Approach, U.S., 2019 – 2029 | 211 |
Figure 6‑40: Outpatient Hysterectomy Procedures by Approach, U.S., 2019 – 2029 | 212 |
Figure 6‑41: Video-Assisted Thoracoscopic Surgery Procedures by Setting, U.S., 2019 – 2029 | 213 |
Figure 7‑1: Laparoscope Market by Segment, U.S., 2019 – 2029 (US$M) | 217 |
Figure 7‑2: Rod Lens Laparoscope Market by Segment, U.S., 2019 – 2029 (US$M) | 219 |
Figure 7‑3: Total Rod Lens Laparoscope Market, U.S., 2019 – 2029 | 220 |
Figure 7‑4: Diagnostic Rod Lens Laparoscope Market, U.S., 2019 – 2029 | 221 |
Figure 7‑5: Operating Rod Lens Laparoscope Market, U.S., 2019 – 2029 | 222 |
Figure 7‑6: Video Laparoscope Market, U.S., 2019 – 2029 | 223 |
Figure 7‑7: Lens Antifog Solution Market, U.S., 2019 – 2029 | 224 |
Figure 7‑8: Leading Competitors, Laparoscope Market, U.S., 2022 | 230 |
Figure 8‑1: Access Device Market by Segment, U.S., 2019 – 2029 (US$M) | 234 |
Figure 8‑2: Total Trocar Market by Segment, U.S., 2019 – 2029 (US$M) | 236 |
Figure 8‑3: Total Trocar Market, U.S., 2019 – 2029 | 237 |
Figure 8‑4: Disposable Trocar Market, U.S., 2019 – 2029 | 238 |
Figure 8‑5: Reposable Trocar Market, U.S., 2019 – 2029 | 239 |
Figure 8‑6: Reusable Trocar Market, U.S., 2019 – 2029 | 240 |
Figure 8‑7: Single-Port Access Device Market, U.S., 2019 – 2029 | 241 |
Figure 8‑8: Leading Competitors, Access Device Market, U.S., 2022 | 245 |
Figure 9‑1: Laparoscopic Hand Instrument Market by Instrument Type, U.S., 2019 – 2029 (US$M) | 249 |
Figure 9‑2: Laparoscopic Hand Instrument Market by Device Function, U.S., 2019 – 2029 (US$M) | 251 |
Figure 9‑3: Reusable Hand Instrument Market, U.S., 2019 – 2029 | 252 |
Figure 9‑4: Disposable Hand Instrument Market, U.S., 2019 – 2029 | 253 |
Figure 9‑5: Reposable Hand Instrument Market, U.S., 2019 – 2029 | 254 |
Figure 9‑6: Articulating Hand Instrument Market, U.S., 2019 – 2029 | 256 |
Figure 9‑7: Grasping Instrument Market, U.S., 2019 – 2029 | 257 |
Figure 9‑8: Cutting Instrument Market, U.S., 2019 – 2029 | 258 |
Figure 9‑9: Leading Competitors, Laparoscopic Hand Instrument Market, U.S., 2022 | 263 |
Figure 10‑1: Insufflation Device Market by Segment, U.S., 2019 – 2029 (US$M) | 267 |
Figure 10‑2: Insufflator Market, U.S., 2019 – 2029 | 269 |
Figure 10‑3: Insufflator Tubing Market by Segment, U.S., 2019 – 2029 (US$M) | 271 |
Figure 10‑4: Total Insufflator Tubing Market, U.S., 2019 – 2029 | 271 |
Figure 10‑5: Standard Insufflator Tubing Market, U.S., 2019 – 2029 | 272 |
Figure 10‑6: Heated Insufflator Tubing Market, U.S., 2019 – 2029 | 273 |
Figure 10‑7: Smoke Evacuation Insufflator Tubing Market, U.S., 2019 – 2029 | 274 |
Figure 10‑8: Veress Needle Market, U.S., 2019 – 2029 | 275 |
Figure 10‑9: Leading Competitors, Insufflation Device Market, U.S., 2022 | 280 |
Figure 11‑1: Suction-Irrigation Device Market by Segment, U.S., 2019 – 2029 (US$M) | 284 |
Figure 11‑2: Disposable Kit Market by Segment, U.S., 2016 – 2026 | 286 |
Figure 11‑3: Battery-Powered Disposable Kit Market, U.S., 2019 – 2029 | 287 |
Figure 11‑4: Hybrid Disposable Kit Market, U.S., 2019 – 2029 | 288 |
Figure 11‑5: Capital Equipment Disposable Kit Market, U.S., 2019 – 2029 | 289 |
Figure 11‑6: Total Reusable Tip Market, U.S., 2019 – 2029 (US$M) | 290 |
Figure 11‑7: Reusable Tip Market by Segment, U.S., 2019 – 2029 | 291 |
Figure 11‑8: Standard Reusable Tip Market, U.S., 2019 – 2029 | 292 |
Figure 11‑9: Electrocautery Reusable Tip Market, U.S., 2019 – 2029 | 293 |
Figure 11‑10: Suction-Irrigation Pump Market, U.S., 2019 – 2029 | 294 |
Figure 11‑11: Leading Competitors, Suction-Irrigation Device Market, U.S., 2022 | 298 |
Figure 12‑1: Direct Energy Device Market by Segment, U.S., 2019 – 2029 (US$M) | 302 |
Figure 12‑2: Total Monopolar Direct Energy Device Market, U.S., 2019 – 2029 | 305 |
Figure 12‑3: Monopolar Direct Energy Device Market by Segment, U.S., 2019 – 2029 | 305 |
Figure 12‑4: Total Monopolar Electrode Market, U.S., 2019 – 2029 | 306 |
Figure 12‑5: Monopolar Electrode Market by Segment, U.S., 2019 – 2029 | 307 |
Figure 12‑6: Disposable Monopolar Electrode Market, U.S., 2019 – 2029 | 308 |
Figure 12‑7: Reusable Monopolar Electrode Market, U.S., 2019 – 2029 | 309 |
Figure 12‑8: Patient Return Electrode Market, U.S., 2019 – 2029 | 310 |
Figure 12‑9: Total Monopolar Hand Device Market, U.S., 2019 – 2029 | 311 |
Figure 12‑10: Monopolar Hand Device Market by Segment, U.S., 2019 – 2029 | 312 |
Figure 12‑11: Electrosurgical Pencil Market, U.S., 2019 – 2029 | 313 |
Figure 12‑12: Monopolar Instrument Market, U.S., 2019 – 2029 | 314 |
Figure 12‑13: Total Bipolar Direct Energy Device Market, U.S., 2019 – 2029 | 315 |
Figure 12‑14: Bipolar Direct Energy Device Market by Segment, U.S., 2019 – 2029 | 316 |
Figure 12‑15: Standard Bipolar Device Market, U.S., 2019 – 2029 | 317 |
Figure 12‑16: Advanced Bipolar Device Market, U.S., 2019 – 2029 | 318 |
Figure 12‑17: Electrosurgical Generator Market, U.S., 2019 – 2029 | 320 |
Figure 12‑18: Leading Competitors, Direct Energy Device Market, U.S., 2022 | 325 |
Figure 12‑19: Leading Competitors, Monopolar Direct Energy Device Market, U.S., 2022 | 327 |
Figure 12‑20: Leading Competitors, Direct Energy Device Market, U.S., 2022 | 328 |
Figure 13‑1: Ultrasonic Device Market by Segment, U.S., 2019 – 2029 (US$M) | 331 |
Figure 13‑2: Reposable Ultrasonic Instrument Market, U.S., 2019 – 2029 | 334 |
Figure 13‑3: Ultrasonic Generator Market, U.S., 2019 – 2029 | 335 |
Figure 13‑4: Leading Competitors, Ultrasonic Device Market, U.S., 2022 | 339 |
Figure 14‑1: Hand-Assisted Laparoscopic Sleeve Market, U.S., 2019 – 2029 | 342 |
Figure 14‑2: Leading Competitors, Hand-Assisted Laparoscopic Sleeve Market, U.S., 2022 | 345 |
Figure 15‑1: Closure Device Market by Segment, U.S., 2019 – 2029 (US$M) | 349 |
Figure 15‑2: Laparoscopic Stapler Market by Segment, U.S., 2019 – 2029 | 352 |
Figure 15‑3: Laparoscopic Stapler Firing Gun Market, U.S., 2019 – 2029 | 353 |
Figure 15‑4: Laparoscopic Stapler Cartridge Market, U.S., 2019 – 2029 | 354 |
Figure 15‑5: Total Endosuturing Device Market, U.S., 2019 – 2029 | 355 |
Figure 15‑6: Endosuturing Device Market by Segment, U.S., 2019 – 2029 | 356 |
Figure 15‑7: Suture Market, U.S., 2019 – 2029 | 357 |
Figure 15‑8: Suture Needle Market, U.S., 2019 – 2029 | 358 |
Figure 15‑9: Laparoscopic Needle Holder Market, U.S., 2019 – 2029 | 359 |
Figure 15‑10: Automated Suturing Device Market, U.S., 2019 – 2029 | 360 |
Figure 15‑11: Total Clip Device Market, U.S., 2019 – 2029 | 362 |
Figure 15‑12: Clip Applier Market by Segment, U.S., 2019 – 2029 | 362 |
Figure 15‑13: 5-mm Disposable Clip Applier Market, U.S., 2019 – 2029 | 363 |
Figure 15‑14: 10-mm Disposable Clip Applier Market, U.S., 2019 – 2029 | 364 |
Figure 15‑15: 10 mm Clips for Reposable Clip Applier Market, U.S., 2019 – 2029 | 365 |
Figure 15‑16: Leading Competitors, Closure Device Market, U.S., 2022 | 369 |
Figure 16‑1: Gastric Device Market by Segment, U.S., 2019 – 2029 (US$M) | 373 |
Figure 16‑2: Gastric Band Market, U.S., 2019 – 2029 | 376 |
Figure 16‑3: Gastric Balloon Market, U.S., 2019 – 2029 | 378 |
Figure 16‑4: Leading Competitors, Gastric Device Market, U.S., 2022 | 382 |
Figure 17‑1: Powered Morcellator Market by Segment, U.S., 2019 – 2029 (US$M) | 387 |
Figure 17‑2: Total Powered Morcellator Market, U.S., 2019 – 2029 | 389 |
Figure 17‑3: Disposable Powered Morcellator Market, U.S., 2019 – 2029 | 390 |
Figure 17‑4: Reposable Powered Morcellator Market, U.S., 2019 – 2029 | 391 |
Figure 17‑5: Leading Competitors, Powered Morcellator Market, U.S., 2022 | 395 |